Using high throughput screening to define virus clearance by chromatography resins

Lisa Connell-Crowley1, Elizabeth A Larimore, Ron Gillespie

  • 1Drug Substance Development, Amgen Inc., 1201 Amgen Court West, Seattle, WA 98119, USA. connelll@amgen.com

Related Concept Videos